Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib is effective and safe for treating severe alopecia areata.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Intralesional steroid therapy is useful for treating various skin conditions.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Intralesional triamcinolone acetonide via Dermojet is highly effective for treating alopecia areata.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Adding a second method to PROTACs could improve cancer treatment.